Literature DB >> 34071438

HspB4/αA-Crystallin Modulates Neuroinflammation in the Retina via the Stress-Specific Inflammatory Pathways.

Madhu Nath1, Yang Shan1, Angela M Myers1, Patrice Elie Fort1,2.   

Abstract

PURPOSE: We have previously demonstrated that HspB4/αA-crystallin, a molecular chaperone, plays an important intrinsic neuroprotective role during diabetes, by its phosphorylation on residue 148. We also reported that HspB4/αA-crystallin is highly expressed by glial cells. There is a growing interest in the potential causative role of low-grade inflammation in diabetic retinopathy pathophysiology and retinal Müller glial cells' (MGCs') participation in the inflammatory response. MGCs indeed play a central role in retinal homeostasis via secreting various cytokines and other mediators. Hence, this study was carried out to delineate and understand the regulatory function of HspB4/αA-crystallin in the inflammatory response associated with metabolic stresses.
METHODS: Primary MGCs were isolated from knockout HspB4/αA-crystallin mice. These primary cells were then transfected with plasmids encoding either wild-type (WT), phosphomimetic (T148D), or non-phosphorylatable mutants (T148A) of HspB4/αA-crystallin. The cells were exposed to multiple metabolic stresses including serum starvation (SS) or high glucose with TNF-alpha (HG + T) before being further evaluated for the expression of inflammatory markers by qPCR. The total protein expression along with subcellular localization of NF-kB and the NLRP3 component was assessed by Western blot.
RESULTS: Elevated levels of IL-6, IL-1β, MCP-1, and IL-18 in SS were significantly diminished in MGCs overexpressing WT and further in T148D as compared to EV. The HG + T-induced increase in these inflammatory markers was also dampened by WT and even more significantly by T148D overexpression, whereas T148A was ineffective in either stress. Further analysis revealed that overexpression of WT or the T148D, also led to a significant reduction of Nlrp3, Asc, and caspase-1 transcript expression in serum-deprived MGCs and nearly abolished the NF-kB induction in HG + T diabetes-like stress. This mechanistic effect was further evaluated at the protein level and confirmed the stress-dependent regulation of NLRP3 and NF-kB by αA-crystallin.
CONCLUSIONS: The data gathered in this study demonstrate the central regulatory role of HspB4/αA-crystallin and its modulation by phosphorylation on T148 in retinal MGCs. For the first time, this study demonstrates that HspB4/αA-crystallin can dampen the stress-induced expression of pro-inflammatory cytokines through the modulation of multiple key inflammatory pathways, therefore, suggesting its potential as a therapeutic target for the modulation of chronic neuroinflammation.

Entities:  

Keywords:  Müller glial cells; NF-kB; inflammatory markers; metabolic stress; αA-crystallin

Year:  2021        PMID: 34071438     DOI: 10.3390/jcm10112384

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  62 in total

1.  Cleavage of amino acid residue(s) from the N-terminal region of alpha A- and alpha B-crystallins in human crystalline lens during aging.

Authors:  A Kamei; H Iwase; K Masuda
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

2.  Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy.

Authors:  Chikako Harada; Akinori Okumura; Kazuhiko Namekata; Kazuaki Nakamura; Yoshinori Mitamura; Hiroshi Ohguro; Takayuki Harada
Journal:  Diabetes Res Clin Pract       Date:  2006-05-30       Impact factor: 5.602

3.  Serum inflammatory markers in diabetic retinopathy.

Authors:  Annal D Meleth; Elvira Agrón; Chi-Chao Chan; George F Reed; Kiran Arora; Gordon Byrnes; Karl G Csaky; Frederick L Ferris; Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

4.  Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin.

Authors:  J P Brady; D Garland; Y Duglas-Tabor; W G Robison; A Groome; E F Wawrousek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  CRALBP supports the mammalian retinal visual cycle and cone vision.

Authors:  Yunlu Xue; Susan Q Shen; Jonathan Jui; Alan C Rupp; Leah C Byrne; Samer Hattar; John G Flannery; Joseph C Corbo; Vladimir J Kefalov
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

Review 6.  Role of Purines in Müller Glia.

Authors:  Andreas Reichenbach; Andreas Bringmann
Journal:  J Ocul Pharmacol Ther       Date:  2016-10       Impact factor: 2.671

7.  Pyruvate kinase and aspartate-glutamate carrier distributions reveal key metabolic links between neurons and glia in retina.

Authors:  Ken J Lindsay; Jianhai Du; Stephanie R Sloat; Laura Contreras; Jonathan D Linton; Sally J Turner; Martin Sadilek; Jorgina Satrústegui; James B Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

8.  Influence of protein-glutathione mixed disulfide on the chaperone-like function of alpha-crystallin.

Authors:  M Cherian; J B Smith; X Y Jiang; E C Abraham
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

9.  Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling.

Authors:  Ashok Kumar; Nazeem Shamsuddin
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

Review 10.  Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach.

Authors:  María Constanza Potilinski; Valeria Lorenc; Sofía Perisset; Juan Eduardo Gallo
Journal:  Int J Mol Sci       Date:  2020-03-28       Impact factor: 5.923

View more
  9 in total

Review 1.  Small Heat Shock Proteins in Retinal Diseases.

Authors:  Vivian Rajeswaren; Jeffrey O Wong; Dana Yabroudi; Rooban B Nahomi; Johanna Rankenberg; Mi-Hyun Nam; Ram H Nagaraj
Journal:  Front Mol Biosci       Date:  2022-04-11

Review 2.  Regulations of Retinal Inflammation: Focusing on Müller Glia.

Authors:  Yingying Chen; Qinghong Xia; Yue Zeng; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-27

3.  Loss of αA or αB-Crystallin Accelerates Photoreceptor Cell Death in a Mouse Model of P23H Autosomal Dominant Retinitis Pigmentosa.

Authors:  Tiantian Wang; Jingyu Yao; Lin Jia; Patrice E Fort; David N Zacks
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

4.  Evidence for Paracrine Protective Role of Exogenous αA-Crystallin in Retinal Ganglion Cells.

Authors:  Madhu Nath; Zachary B Sluzala; Ashutosh S Phadte; Yang Shan; Angela M Myers; Patrice E Fort
Journal:  eNeuro       Date:  2022-03-04

5.  Proteomic Analysis of Retinal Mitochondria-Associated ER Membranes Identified Novel Proteins of Retinal Degeneration in Long-Term Diabetes.

Authors:  Joshua J Wang; Karen Sophia Park; Narayan Dhimal; Shichen Shen; Xixiang Tang; Jun Qu; Sarah X Zhang
Journal:  Cells       Date:  2022-09-09       Impact factor: 7.666

6.  State-of-the-Art Research on Diabetic Retinopathy.

Authors:  Rafael Simó
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

7.  Crystallins Play a Crucial Role in Glaucoma and Promote Neuronal Cell Survival in an In Vitro Model Through Modulating Müller Cell Secretion.

Authors:  Hanhan Liu; Katharina Bell; Anja Herrmann; Stefan Arnhold; Karl Mercieca; Fabian Anders; Kerstin Nagel-Wolfrum; Solon Thanos; Verena Prokosch
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

Review 8.  Therapeutic Potential of α-Crystallins in Retinal Neurodegenerative Diseases.

Authors:  Ashutosh S Phadte; Zachary B Sluzala; Patrice E Fort
Journal:  Antioxidants (Basel)       Date:  2021-06-23

Review 9.  Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways.

Authors:  Nadine Auler; Henrik Tonner; Norbert Pfeiffer; Franz H Grus
Journal:  Biology (Basel)       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.